| Absence of Comorbidities (n = 11) | Presence of comorbidities (n = 17) | P* |
Age, MD ± SD, y | 55.3 ± 9.2 | 61.4 ± 10.6 | 0.128 |
Male, n, (%) | 5 (45.5) | 11 (64.7) | 0.441 |
Albumin (g/L) |
|
|
|
baseline | 36.5 ± 3.8 | 35.3 ± 4.8 | 0.430 |
extremum | 32.7 ± 4.6 | 30.5 ± 5.3 | 0.254 |
P# | 0.047 | 0.010 |
|
Alanine aminotransferase × U/L |
|
|
|
baseline | 33.0 (21.0, 63.0) | 39.0 (27.3, 60.0) | 0.677 |
extremum | 81.0 (54.0, 137.0) | 78.0 (48.5, 109.5) | 0.285 |
P# | 0.013 | 0.009 |
|
Aspartate aminotransferase × U/L |
|
|
|
baseline | 42.4 ± 16.2 | 49.0 ± 21.8 | 0.375 |
extremum | 62.0 (41.0, 92.0) | 57.0 (48.0, 68.5) | 0.175 |
P# | 0.023 | 0.274 |
|